Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=71

Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

CRC

Bottom Line

View on ClinicalTrials.gov: NCT02161549 ↗
Enrolled (actual)
71
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Mean Score of Boston Bowel Preparation Scale (BBPS) Index Prior and After the Use of MotusGI CleanUp System — 2.9; 2.9 units on a scale

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Motus Gl CleanUp System (Device)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
Motus GI Medical Technologies Ltd
Primary completion
Oct 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Score of Boston Bowel Preparation Scale (BBPS) Index Prior and After the Use of MotusGI CleanUp System		 2.9; 2.9 —

Summary

Motus Gl is developing a single-use device that attaches to a standard colonoscope, thereby integrating colon cleansing, screening and treatment into one procedure. The device creates turbulence within the colon using water jets. The colon's fecal fluids are evacuated by the system.

Eligibility Criteria

Inclusion Criteria

  • Subjects in the age range of 50-69 years
  • Subjects who are considered for routine screening colonoscopy
  • Subjects with BMI within the range of 18.5-30
  • Subject is willing to sign informed consent form

Exclusion Criteria

  • History of G diseases or history of Colorectal cancer (personal or family)
  • Previous major abdominal surgeries
  • Medical status ASA grater or equal to 3
  • Acute Gl symptoms, such as bleeding, unexplained weight loss, inflammatory bowel disease (lBD).
  • Patients taking anticoagulants (e.g., Coumadin, Heparin, Clopidrogrel)
  • Life-threatening condition
  • Subjects who are unable or unwilling to cooperate with study procedures
  • Severe Diverticula
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02161549). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search